Short‐term effects of SAFE early intervention approach in infants born preterm: A randomized controlled single‐blinded study
Brain and Behavior · 2023
DOI: 10.1002/brb3.3199 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Brain and Behavior, 2023. Verfasst von Umut Apaydın und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Karadeniz Technical University, Trabzon, Turkey. Hauptthemen laut MEDLINE: Infant, Premature, Child Development, Early Intervention, Educational, Early Medical Intervention. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Recent literature suggests that goal‐oriented and family‐based interventions in enriched environment have a beneficial effect on neuromotor and cognitive development. We aimed to examine the short‐term effects of SAFE ( S ensory strategies, A ctivity‐based motor training, F amily collaboration, and E nvironmental Enrichment) early intervention approach on motor, cognitive, speech and language, and sensory development in preterm infants.
Methods
The study's sample population consisted of 24 preterm infants with corrected ages between 9 and 10 months. Infants in the control group participated in the family training program in accordance with the neurodevelopmental therapy principles (NDT). Infants in the treatment group were included in the family training program according to the principles of the SAFE Early Intervention Approach. Affordances in the Home Environment for Motor Development‐Infant Scale (AHEMD‐IS), Test of Sensory Functions in Infants (TSFI), Canadian Occupational Performance Measure (COPM), and Bayley Scales of Infant and Toddler Development III (Bayley III) were used to evaluate infants in both groups before and after 10 weeks of treatment (AHEMD‐IS). The Depression, Anxiety, Stress Scale Short Form was used to assess the parents’ mental health (DASS‐SF).
Results
The interaction effects (time × group) revealed significant differences for Bayley‐III cognitive and language scores, TSFI total score, and AHEMD‐IS total score in favor of the SAFE group ( p < .05). However, there were no differences in Bayley‐III motor composite score, COPM Performance score, and COPM Satisfaction score between the interaction effects (time × group) of the groups ( p > .05).
Conclusions
SAFE early intervention approach improved cognitive, speech and language, sensory outcomes and provide enriched home environment in all domains when compared to NDT‐based home program. SAFE is a promising novel early intervention approach for preterm infants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Karadeniz Technical University, Trabzon, Turkey.
- Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Gazi University, Ankara, Turkey.
- Faculty of Medicine, Department of Pediatrics, Section of Pediatric Neurology, Gazi University, Ankara, Turkey.
ORCID-Profile: Umut Apaydın
Zitieren
APA
Apaydın, U., Yıldız, R., Yıldız, A., Acar, Ş. S., Gücüyener, K., & Elbasan, B. (2023). Short‐term effects of SAFE early intervention approach in infants born preterm: A randomized controlled single‐blinded study. Brain and Behavior. https://doi.org/10.1002/brb3.3199
Vancouver
Apaydın U, Yıldız R, Yıldız A, Acar ŞS, Gücüyener K, Elbasan B. Short‐term effects of SAFE early intervention approach in infants born preterm: A randomized controlled single‐blinded study. Brain and Behavior. 2023. doi:10.1002/brb3.3199
BibTeX
@article{Apaydn2023,
author = {Apaydın, Umut and Yıldız, Ramazan and Yıldız, Ayşe and Acar, Şebnem Soysal and Gücüyener, Kıvılcım and Elbasan, Bülent},
title = {Short‐term effects of SAFE early intervention approach in infants born preterm: A randomized controlled single‐blinded study},
journal = {Brain and Behavior},
year = {2023},
doi = {10.1002/brb3.3199}
}
EUVIMED